Impact Factor 5.201 | CiteScore 5.8
More on impact ›
This section's aim is to bring together carefully designed and conducted basic research into the molecular and cellular mechanisms of carcinogenesis and cancer progression. Special interest falls on novel mechanistic insights into cancer molecular pathways and pathogenic cellular transformation.
This section is devoted to the publication of high-quality basic research in the molecular and cellular mechanisms contributing to cancer development and progression.
We aim to describe and highlight novel mechanistic insights into molecular pathways and cellular processes involved in oncogenesis, irrespective of the precise type of malignancy. The areas of interest include cell growth regulation, DNA damage and repair, signal transduction, metabolic reprogramming, cell death, sustained angiogenesis, tissue invasion and metastasis, avoidance of immunosurveillance, and tumor microenvironment. Submissions describing pathogenetic mechanisms of cellular transformation are of particular interest. In addition, transcriptomics, proteomics and metabolomics studies, which reveal new cellular or biochemical aspects of cancer biology are also welcomed.
Descriptive transcriptomics studies as well as those consisting solely of bioinformatic investigation of publicly available genomic / transcriptomic data without experimental or in situ validation to support conclusions are not in scope for this Section.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Web of Science Science Citation Index Expanded (SCIE), Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Ulrich's Periodicals Directory, CLOCKSS, OpenAIRE
Molecular and Cellular Oncology welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge, Systematic Review and Technology and Code.
All manuscripts must be submitted directly to the section Molecular and Cellular Oncology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact email@example.com
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact firstname.lastname@example.org